SNMMI Therapeutics Conference 2019

Viewing 1-12 of 12 articles

SNMMI 2019: Licensing and Regulatory Requirements for Targeted Alpha Therapies

SNMMI 2019: Overview of the Meeting and Roadmap to the Future of Radionuclide Therapy

SNMMI 2019: Co-Managing the Patient with Metastatic Castration-Resistant Prostate Cancer

SNMMI 2019: Current Status of 177 Lu-PSMA Targeted Therapies and Where Will We Be In the Near Future

SNMMI 2019: Overview of the Treatment Landscape in Castration-Resistant Prostate Cancer

SNMMI 2019: Current and Future Role of Radium 223 in Prostate Cancer

SNMMI 2019: Regulatory and Radiation Safety Requirements for Radiopharmaceutical Therapy

SNMMI 2019: Reintroducing Therapeutics: Nuclear Medicine Physician Leading Patient Care Team

SNMMI 2019: Operationalizing Your Practice for 177Lu-PSMA Based Therapies

SNMMI 2019: Operationalizing Your Practice for 223Ra-Dichloride

SNMMI 2019: Operationalizing a 177Lu-Dotatate Clinic

SNMMI 2019: Establishing Your Practice in Systemic Radiation Therapy in Theranostics Practice / The Role of Technologists in Theranostics Practice